North Mississippi Medical Center (Tupelo) Family Medicine

Topics

• Sphingolipid Metabolism and Signaling 6
• Abdominal Trauma and Injuries 3
• Neuropeptides and Animal Physiology 3
• Pregnancy and preeclampsia studies 3
• Thyroid and Parathyroid Surgery 2
• Thyroid Cancer Diagnosis and Treatment 2
• Attention Deficit Hyperactivity Disorder 1
• Bipolar Disorder and Treatment 1
• Botulinum Toxin and Related Neurological Disorders 1
• Cancer Diagnosis and Treatment 1
• Cardiovascular Effects of Exercise 1
• Chromosomal and Genetic Variations 1

Most cited

1. Overview of Psychiatric Medications in the Pipeline in Phase III Trials as of June 1, 2024: A Systematic Review.

   Innovations in clinical neuroscience · 2024 · 8 citations · Rasha Abdelsalam

2. IL-33 supplementation improves uterine artery resistance and maternal hypertension in response to placental ischemia.

   American journal of physiology. Heart and circulatory physiology · 2024 · 9 citations · Greagory Peacock

3. Depressive disorders: systematic review of approved psychiatric medications (2009-April 2025) and pipeline phase 3 medications.

   BMC psychiatry · 2025 · 5 citations · Rasha Abdelsalam

4. Progressive Reduction in Right Ventricular Contractile Function Attributable to Altered Actin Expression in an Aging Mouse Model of Arrhythmogenic Cardiomyopathy.

   Circulation · 2022 · 14 citations · Joseph Alef

5. Blood-Brain Barrier Dysfunction in Hypertensive Disorders of Pregnancy.

   Current hypertension reports · 2023 · 8 citations · Simranjit Kaur

6. Dolutegravir Inhibits Proliferation and Motility of BT-20 Tumor Cells Through Inhibition of Human Endogenous Retrovirus Type K.

   Cureus · 2022 · 11 citations · Lauren Robbins